2 of released O-linked oligosaccharides and a thorough description of the glycosylation of this molecule, where high-molecular-weight oligosaccharides up to the size of 2790 Da and with up to three sialic acid residues were identified. A common theme of these novel high abundant oligosaccharides on MUC7 showed that the C-3 branch of the oligosaccharides consisted of branched I-antigen type structural epitopes (GlcNAcβ1-3(GlcNAcβ1-6)Galβ1-), where the branch point was initiated on core 1 and core 2 galactose residues, and the branches were terminated by sialyl type 2 and sialyl Lewis x epitopes. Six sulfated sialylated oligosaccharides of low intensity were also identified, with the sulfate mainly on N-acetyl glucosamine residues located close to the reducing termini. One of these oligosaccharides was identified as a candidate for the high-affinity L-selectin ligand 6 -sulfo sialyl Lewis x. Neutral oligosaccharides and blood group antigens were found to be less abundant on MUC7 and the glycosylation appeared to be more preserved between individuals as compared to salivary MUC5B. This was illustrated by comparing the LC-MS spectra of MUC7 and MUC5B glycans from secretors (23 individuals) and nonsecretors (6 individuals). The data show that MUC7 provides a multivalent scaffold for sialylation, meeting the requirement for high-avidity binding via its glycosylation and mediator of the interaction between immune cells such as salivary neutrophils and oral bacteria.
Introduction
Mucins are high-molecular-weight glycoproteins present on all mucosal surfaces. There are different categories of mucins, such as multimerizing mucins creating gel like macrostructures serving as lubrication of the mucosal surfaces, while other mucins are membrane bound. Among the classical multimerizing mucins are, for instance, MUC2, MUC5B, MUC5AC, and MUC6, while MUC1, MUC3, and MUC4 are membrane bound (Dekker et al. 2002; Theodoropoulos and Carraway 2007) , but may be shed from the surfaces as soluble monomers. MUC7 is somewhat unique, as it is secreted only as a single soluble unit (Bobek et al. 1993) . The mucins are characterized by the presence of tandemly repeated amino acid sequences, the mucin domains that contain high amounts of serine and threonine and thus create an attachment point for O-linked glycosylation. There are currently 20 mucin genes identified (Lindén et al. 2008) , but the prevalence of mucin domains also on other proteins emphasizes that mucins are not a homogenous family; the only common denominator is the presence of a mucin domain, and other functional aspects of mucins may vary significantly.
The O-linked glycosylation on mucins is anchored via GalNAcα1-Ser/Thr with extension on both C-3 and C-6. The heterogenous glycosylation of the mucin domains creates large protease resistant areas designed for the interaction via multivalent specific and/or nonspecific oligosaccharide patches. The nonspecific interaction (believed to occur via a multitude of hydrogen bonds via -OH and -NH) are enhanced with the inclusion of charges provided by the sulfation and sialylation of the oligosaccharides, while specific interactions such as between mucin and bacteria can occur via particular oligosaccharide epitopes such as Si-Le x/a and Le b (e.g., Helicobacter pylori interaction) (Ilver et al. 1998; Mahdavi et al. 2002) .
Salivary mucins are a dominating component in human saliva. One main component is the salivary version of MUC7, identified as the major mucin in the low-molecular-weight mucin fraction called mucin glycoprotein 2 (MG2) (Bobek et al. 1993) . The second main apomucin identified in the saliva is the MUC5B, the main component of the high-molecular-weight mucin complex called MG1 (Thornton et al. 1999) . Recently, a third highly glycosylated high-molecular-weight component has been identified, the salivary agglutinin, shown to be a DMBT1 gene product (Prakobphol et al. 2000) . The DMBT1 gene displays many of the characteristics of an apomucin, with repeated regions containing the high amount of Ser/Thr. However, it has been shown that part of these regions (the SRCR domains) are only sparsely glycosylated in the salivary agglutinin (Prakobphol et al. 2000) , leaving only the repeated SID domains (SRCR interspersed domains) containing the high amount of serine as the major sites for O-linked glycosylation. Detailed characterization of salivary agglutinin oligosaccharides is yet to be performed.
Salivary MG2-MUC7 has been suggested to be important for binding of salivary neutrophils via L-selectin (Prakobphol et al. 1998) and mediating the interaction between neutrophils and oral bacteria (Prakobphol et al. 1999) . Epitopes such as sulfation (as defined by the antigen for the MECA-79 antibody) and Si-Le x in the oral cavity expressed on MG1, MG2, and salivary agglutinin have been proposed to be important for neutralizing oral bacteria and for the recruitment of neutrophils in the oral cavity (Prakobphol et al. 2005) . The i-antigen is characterized as repeated linear polylactosamine units, whereas the I-antigen contains additional branched polylactosamine, by the addition of GlcNAc-linked β1-6 to Gal and followed by Gal-linked β1-4 to the GlcNAc residue. R 1 and R 2 stand for oligosaccharide chain extension on each of the branches, respectively.
Saliva has frequently been used as a source for elucidating human O-linked glycosylation pathways performing structural characterization of isolated oligosaccharide (Klein et al. 1992; Slomiany et al. 1993) . The sources of these oligosaccharides have usually been mixtures of different mucin components, and it is only recently that well-defined individual salivary mucins could be isolated and analytical techniques allowed extensive glycomic analysis of these components to be performed. The oligosaccharide blood group I and i antigens are of particular interest for this report (Figure 1 ), as it was discovered already in the 1970s that the I-antigen was present in a soluble form in saliva (Dzierzkowa-Borodej et al. 1970) , and it has been indicated that blood group I substances are linked to salivary mucins (Slomiany et al. 1993) . Previous characterization of MG2 oligosaccharides has been performed using enzymatical, immunological, mass spectrometric and NMR techniques, and structural features of the oligosaccharides have been deduced, including the sequences of smaller MG2 oligosaccharides (Reddy et al. 1985; Prakobphol et al. 1998) . Reports have also highlighted that only a portion of the MG2 oligosaccharides has been described (Schulz et al. 2002; Thomsson et al. 2002) and that the molecular description of MG2 was insufficient to account for the function of this molecule, where its ability to interact with its environment is the key. Also, while it is known that MG1 glycosylation varies depending on the blood group and secretor status of individuals (Thomsson et al. 2005 ), this relation is unexplored for the glycosylation of MG2. This report is addressing these issues, by isolating MG2 by agarose/polyacrylamide composite gel electrophoresis (SDS-AgPAGE) and using a combination of highly sensitive negative ion nano LC-MS and MS n experiments (Schulz et al. 2002) in conjunction with sialidase treatment, to provide a comprehensive biochemical description of MG2 glycosylation and its variation between individuals.
Results

Western blots of mucins in saliva separated with SDS-AgPAGE show differential glycosylation
As part of an initial screen of the glycosylation of salivary mucin components, and to optimize the conditions for separation and detection of MG2, whole saliva from a blood group H secretor was subjected to SDS-AgPAGE. This revealed two Alcian blue staining regions (Figure 2 ) indicating the presence of highly charged mucins. Staining with Alcian blue at "high" pH (pH ∼ 1, Fig. 2 . SDS-AgPAGE and western blot of human saliva. Human saliva from a blood group H secretor was subjected to gel electrophoresis and blotted onto PVDF-membranes. Salivary components were detected with antibodies against Sulfo-Le a , blood group H, Si-Le x , Si-Le a and with high pH (∼1) and low pH (∼0) Alcian blue (lanes 1-6, respectively).
and indicative for both NeuAc and sulfate) displayed in lane 5 in Figure 2 , detected both MG1 (1-2 MDa region) and MG2 (200 kDa region), while staining with Alcian blue at low pH (pH ∼ 0, and indicative for only sulfate) preferentially stained MG1 (Figure 2 , lane 6), indicating that the amount of sulfation was significantly higher on MG1 compared to MG2. This is also consistent with previous monosaccharide analysis of MG2 oligosaccharides, suggesting that only a minor portion of the chains (∼11%) contained sulfate residues (Thomsson et al. 2002) . Western blotting with an antibody against Si-Le x showed that both MG1 and MG2 contained this epitope ( Figure  2 , lane 3). We also found a third component reacting with the antibody, identified in the area (400 kDa region) where the salivary agglutinin (encoded by the DMBT1 gene) was expected. This identity of the protein was later verified with proteomics (result not shown). Staining with antibodies against the blood group H (Fucα1-2Galβ1-) and Si-Le a epitopes ( Figure 2 , lanes 2 and 4, respectively) revealed only weak staining of MG2 and salivary agglutinin compared to MG1, where these epitopes appeared to be highly abundant. The sulfation of MG1 indicated by the low pH Alcian staining could partly be explained by the presence of sulfo-Le a epitopes and is consistent with the previous report of structural characterization of MG1 oligosaccharides (Thomsson et al. 2005 ). In conclusion, the results from western blotting and staining of high-molecular-weight salivary components show that individual bands can be isolated corresponding to the high molecular mucin components described in human saliva.
Identification of the protein core of MG2
The MG2 component was detected in the SDS-AgPAGE at a molecular mass of 200 kDa, and MG2 has previously been shown to consist mainly of the MUC7 apomucin (apomucin size of 39 kDa). Peptide mass fingerprinting and LC-MS 2 after tryptic digestion identified four peptides from the MUC7 unglycosylated region (Figure 3) . The low sequence coverage of MUC7 by mass spectrometry can be explained by the fact that 73% of MUC7 is made up of the undigestible and heterogeneous glycosylated mucin domain (aa 75-333 of this 355 aa apomucin). The ion intensity of MUC7 peptides made up 71% of the total intensity of identified peptides, but the low level of MUC5B, and to a lesser extent, DMBT1 peptides were also detected (data not shown). The discrepancy between the size 39 kDa of the MUC7 apomucin and 200 kDa estimated by SDS-AgPAGE size is most likely due to the extensive O-linked glycosylation of MUC7. Based on the differences between measured size and apomucin, the glycosylation of MG2 should be over 80%, which is a typical figure for mucins. Since it has been shown that the presence of acidic sulfated and sialylated oligosaccharides will influence the migration of mucins in gel electrophoresis (Holmén et al. 2004; Thomsson et al. 2005) , the estimation of the amount of glycosylation of MG2 will have to be verified by other methods.
Glycosylation of MG2
Analyzing released oligosaccharides from MG2 from the same individual as above with nano LC-MS and MS 2 , we found that the oligosaccharides displayed a heterogeneous mixture of neutral and acidic oligosaccharides ranging from 3 to 14 monosaccharide units, detected both as singly and doubly negatively charged pseudomolecular ions ( Figure 4 , and supplementary Table I ). More than 100 components were separated on the HPLC column, and MS 2 spectra were generated for 44 individual neutral components and 47 spectra for acidic (sialylated and sulfated) species (Table I and supplementary Table I ). According to the ion intensities, the majority of observed oligosaccharides were sialylated, with up to three NeuAc and/or three fucose residues. Many of the smaller oligosaccharides corresponded to sequences already found on MG2 (Reddy et al. 1985; Prakobphol et al. 1998) , but the larger oligosaccharides were found to be novel, and according to the mass spectrometric intensities, oligosaccharides larger than seven monosaccharide units corresponded to a significant amount of the MG2 oligosaccharides (>40%). While LC-MS 2 could verify that these oligosaccharides were indeed sialylated, the sequence of the larger highly sialylated components could not be elucidated because of the characteristics of their MS 2 spectra, showing little extra information but the loss of sialic acid followed by the loss of hexose, indicating that sialic acid was mainly attached to terminal galactose (Figures 5A and 6A) . To obtain the sequence of the larger sialylated oligosaccharides, we isolated a neutral and acidic fraction of oligosaccharides using a miniaturized anion-exchange procedure, followed by LC-MS 2 of both neutral and acidic oligosaccharides with and without specific sialidase treatment ( Figure 4 ). It was found that the recombinant sialidase for α2-3-linked sialic acid was efficient in removing virtually all sialic acids ( Figure 4D ). This was in accordance with previous results from characterization of MG2 oligosaccharides (Prakobphol et al. 1998) , where the sialic acid has been shown to be α2-3 linked. The removal of up to three sialic acid with the α2-3-linked specific sialidase from MG2 oligosaccharides suggested that it contained oligosaccharides with up to three antennas. Only the low signal of one single potential α2-6-linked sialic acid oligosaccharide with a sequence homologous to the disialylated T-antigen NeuAcα2-3Galβ1-3(NeuAcα2-6)GalNAcol was detected among the MG2 oligosaccharides, which is in line with . Nano LC-MS of oligosaccharides from a blood group H secretor from MG2 isolated by SDS-AgPAGE. Combined mass spectra (RT 20-83 min) of oligosaccharides released by reductive β-elimination (A), neutral oligosaccharides isolated after anion exchange chromatography (B), and acidic oligosaccharides after anion exchange isolation before (C) and after α2-3-specific sialidase treatment (D). Oligosaccharide compositions of major peaks are written as (HexNAc,Hex,Fuc,NeuAc,sulfate).
earlier studies (Prakobphol et al. 1998) . The interpretation of the MS 2 spectra of neutral and desialylated oligosaccharides in the negative ion mode has been shown to be an efficient approach to elucidate the O-glycosylation of mucins. Uncharged oligosaccharides provide diagnostic fragment ions for blood group epitopes, Lewis-type fragmentation, and N-acetyllactosamine elongation ). In addition, the analysis of desialylated sequences also reduced the amount of isomeric compounds (resolved isomeric peaks in LC-MS chromatogram) of the sialylated oligosaccharides of MG2 (Table I and supplementary Table I ), typically detected when the amount of sialic acids is less than the number of antennas.
In accordance with the data from western blotting showing that Si-Le x (NeuAcα2-3Galβ1-4(Fucα1-3)GlcNAcβ1-) was attached to MG2, we did indeed find diagnostic ions for the N-acetyllactosamine elongation of the released oligosaccharides corresponding to the type 2 chain (Galβ1-4GlcNAcβ1-), the same N-acetyllactosamine chain that is the core of the Si-Le x epitope. The high precedence of type 2 chains (Galβ1-4GlcNAcβ1-), detected by their diagnostic fragment ions in MS 2 , and the detection of Si-Le x on MG2 by western blotting and the absence of Si-Le a , suggested that the majority of N-acetyllactosamine chains were type 2. a Assumption is that reducing-end HexNAc is GalNAc ᮀ, nonreducing-end HexNAc is GlcNAc , hexose is Gal ᭺, deoxyheoxose is Fuc based on the previous analysis of MG2 (Thomsson et al. 2002) . b Based on combinatorial calculation of the structure with and without Fucα1-3GlcNAc and NeuAcα2-3Gal or NeuAcα2-6GalNAc, assuming only type 2 configuration of N-acetyllactosamine, blood group I type branching, and core 1 and core 2 structures. c As identified in Figure 4 . Most intense [M − nH] n− ions are written first and less intense ion in paranthesis. d Identified after desialylation ( Figure 4D ). e Based on ion intensity of desialylated structures d . f Sulfated versions of this was also detected by LC-MS. g ND = not detected.
N G Karlsson and K A Thomsson
The amount of sulfate containing oligosaccharides were found to be of low intensity, explaining why the staining using the low pH Alcian blue was not efficient in staining MG2, and the low amount of type 1 chains on MG2 together with low sulfation would make MG2 a poor antigen for the sulfo-Le a antibody (HSO 3 -3Galβ1-3(Fucα1-4)GlcNAcβ1-) since the small amount of sulfated oligosaccharides detected showed predominantly sulfation on GlcNAc (supplementary Table I ).
Branched sialylated core 1 type structures on MG2
The core type 2 enzyme adding GlcNAc to C-6 of the GalNAc has been described as the key enzyme to allow the expression of complex structures such as Si-Le x on O-linked oligosaccharides (Li et al. 1996) . The structural interpretation of oligosaccharides on MG2 in this report highlights an alternative way of forming branched and complex O-glycans, suggesting that the above conclusion is only relevant when the activity of glycosyltransferases, which can block further extension on the C-3 branch, is high. This would be the case, for example, with sialyltransferases or the Fucα1-2 secretor enzyme. We found only low intensities of NeuAcα2-3Galβ1-3GalNAcol (m/z 675) and Fucα1-2Galβ1-3GalNAcol (m/z 530), which would be the direct product of these biochemical reactions. This indicated that oligosaccharides on MG2 are synthesized differently. Instead, we found core 1 structures with more exotic extensions (Table I) . In its simplest form, these oligosaccharides were found to be nonfucosylated oligosaccharides with one or two sialic acid residues. These structures were deduced to have the oligosaccharide backbone of a biantennary N-acetyllactosamine core linked to the Gal residue on the C-3 branch ( Figure 5A and B). The MS 2 spectrum ( Figure 5A ) of the disialylated component eluted Figure 5B ) with the same backbone was detected at 71.57 min and 75.49 min, respectively, illustrating the efficiency of the chromatography being able to separate very closely related isomers. After desialylation, a single isomer was detected corresponding to the mass of the nonsialylated hexasaccharide backbone composition of these oligosaccharides, where the MS 2 spectrum showed low intense, but still distinct fragmentation from the loss of a terminal GalNAcol (parent ions -108 Da and 223 Da ), confirming the assignment as core 1 structures ( Figure 5C ). The lack of B-type ions between m/z 363.6 (B 2α and B 2β ) and 891.3 (B 3 ) in the desialylated spectrum strongly suggested that this had a branched rather than a linear N-acetyllactosamine core.
Branched sialylated core 2 type structures on MG2
One of the dominating ions (m/z 1249.2 2− ) in the mass spectrum in the total mixture and in the acidic fraction of MG2 oligosaccharides spectra was found to be a doubly negatively charged species corresponding to the composition Hex 4 HexNAc 4 Fuc 1 NeuAc 3 (Figure 4 ). There were also less sialylated versions such as m/z 1103.7 2− (Hex 4 HexNAc 4 Fuc 1 NeuAc 2 ) and 958.2 2− (Hex 4 HexNAc 4 Fuc 1 NeuAc 1 ). After desialylation, the corresponding molecular ions without sialic acid were found as prominent [M − xH] x− ions at m/z 1625.6 − and m/z 812.6 2− ( Figure 4D ). The LC-MS of both sialylated and desialylated samples indicated that this composition corresponded to a single isomer since the selective ion chromatogram showed a single dominating LC-MS peak ( Figure 6A-C, insets) . Fragmentation of the triply sialylated species (m/z 1249.2 2− ) showed that it contained three sialic acids ( Figure 6A ), which was confirmed by the sialidase treatment. After desialylation, additional features were highlighted after MS 2 of both the singly and doubly charged precursor ions ( Figure 6B and C) , including the Le a/x -type Z 3 /Z 3 fragmentation and also characteristic 0,2 A 2 ions for type 2 chains , the latter fragments only observed with MS 2 of the doubly charged ion ( Figure 6C ). In conclusion, it was deduced from the MS sequencing that the fully sialylated oligosaccharide would have one antenna containing Si-Le x and two additional sialylated N-acetyllactosamine antennas where at least one contained the type 2 chain. The corresponding desialylated version of the triantennary N-acetyllactosamine backbone sequence was also found without fucose (m/z 1479.5 − ), and with two fucoses (m/z 1771.5 − and 885.6 2− ) and with three fucoses at m/z 958.2 2− (Table I and supplementary Table I ), one fucose for each of the three antennas and each arranged as the Le x -type epitope. These sequences were all found with increasing number of sialic acids, thus deduced to express multiple Si-Le x epitopes in close proximity within an oligosaccharide.
I-type branching of galactose on oligosaccharides as described in Table I and in Figures 5 and 6 has previously been indicated to be present on MG2 (Slomiany et al. 1993 ), but the extent of this type of branching on MG2 has not been realized before. In order to confirm the galactose branching of the m/z 1249.2 2− structure, an LC-MS 3 experiment was carried out where the desialylated 812.6 2− parent ion was collided and the dehydro fragment Z 2α of m/z 1096 − (loss of the Le x moiety) was isolated and fragmented ( Figure 6D ). If the structure were a linear diN-acetyllactosamine on the C-3 branch of GalNAcol, a pronounced Y fragment from the loss of dehydrogalactose (144 Da found, concluding that the structure is the proposed branched triantennary oligosaccharide with one terminal sialic acid on each antenna. The intense 3,5 A fragment ion at m/z 437.8 confirms that an unfucosylated N-acetyl lactosamine is attached to C-6 of a branching galactose.
Neutral oligosaccharides on MG2
The neutral MG2 oligosaccharides were shown to contain a significant amount of blood group H epitopes (Fucα1-2Galβ1-) . When comparing the neutral oligosaccharides with the acidic, the former appeared to contain the majority of blood group determinants present on MG2 (blood group H and Le b/y type sequences), while the latter contained only low intense ions with group H epitopes ( Figure 4A and supplementary Table I ). The observations that the ion intensities of neutral oligosaccharides were relatively low ( Figure 4A ) together with the negative staining of MG2 with the blood group H antibody (Figure 2 lane 2) both suggested that the blood group H containing and neutral oligosaccharides constituted a minor portion on MG2. The smallest blood group H oligosaccharide detected was the fucosylated core 1 trisaccharide detected as an [M − H] − ion at m/z 530.2, which was also one of the neutral oligosaccharides detected with the highest ion intensity. The largest blood group H structure was a biantennary Gal-GlcNAc-(Gal-GlcNAc-)Galol. This structure is believed to be a chemical degradation product of the nonfucosylated core 1 and core 2 I type oligosaccharides. It has been shown that the C-3 branch of GalNAc is easily lost under alkaline conditions, and cannot entirely be eliminated by including reducing agents in the reaction when the oligosaccharide is released from the protein backbone. This data further substantiated that MG2 contained complex glycosylation on the C-3 branch of GalNAcol. Degradation products were also detected in the acidic fraction (supplementary Table I ), all shown to be structures with branching on the reducing-end galactose indicative of degradation of blood group I type oligosaccharides during the chemical release.
Sulfation of MG2 oligosaccharides
Our finding that MG2 oligosaccharides are only scarcely sulfated ( Figure 4 and Table I ) is to some extent a paradox since MG2 have been proposed to be able to bind L-selectin, where the interaction motif has been described as sulfated Si-Le x epitope (McEver 2005) . While it is obvious that sulfation of MG2 needs to be addressed specifically because of the low amount, sequence information after desialylation from six structures could be obtained in this study (supplementary Table I ). This is the first report describing sulfated sequences on MG2 although molecular ions corresponding to sulfated oligosaccharides were previously observed with FAB-MS (Prakobphol et al. 1998) . The sulfated oligosaccharides consisted of up to seven residues, where the sulfate was in most cases linked to a core GlcNAc residue. Sulfation was mainly found on sialylated oligosaccharides. One major sulfated sialylated structure was detected as a doubly (Thomsson et al. 2005 ). The calculation was based upon relative intensities of oligosaccharide peaks in LC-MS chromatograms (see Materials and methods). Included are also data from previous publication based on monosaccharide analysis after hydrolysis from a nonsecretor (Thomsson et al. 2002) .
charged ion at m/z 778.4 2− (Figure 7) . While there is no linkage information obtained in the corresponding MS 2 spectrum, the spectrum obtained after desialylation suggests that the fucose residue is located to GlcNAc in a Le a/x -type configuration since the removal of two sialic acid residues with the sialidase enzyme from Streptococcus pneumonia excludes the possibility of fucose linked to the two terminal galactoses. The absence of any evidence that type 1 N-acetyllactosamine was present in the sample (MS/MS and antibody reactivity) strongly suggests that this is a sulfated Si Le x structure. This sulfated disialylated oligosaccharide would be a candidate as a high-affinity ligand for L-selectin, but is not likely to be a major structure of MG2.
Conserved glycosylation of MG2
Since we previously have shown that salivary MG1 O-glycosylation differs between individuals due to the blood group and secretor status, we were interested to see if the MG2 glycans also varied in a similar manner. In Figure 8 are displayed the base peak LC-MS chromatograms of MG1 and MG2 glycans from six individuals with known blood group and secretor status. As previously shown, the oligosaccharide profiles of MG1 glycans shifted dramatically, but in contrast, the MG2 glycan profiles were found to be very similar, independent of the blood group and secretor status. In total, 29 MG2 glycan profiles were compared from Caucasian and Asian origin, and all displayed the same appearance, with major peaks corresponding to doubly and triply sialylated oligosaccharides at m/z 1331.4
− , m/z 1477.5 − , and m/z 1249.2 2− . The monosaccharide composition was calculated based on mass spectrometric intensities of MG2 glycans from the 29 individuals (Figure 9 ). No significant differences were found comparing the secretors with the nonsecretors, while the opposite was true for MG1, where nonsecretor MG1 oligosaccharides were found to be highly sialylated (Thomsson et al. 2005) . Comparing the quantification using mass spectrometry and the one made previously using monosaccharide analysis after acidic hydrolysis of MUC7 from a nonsecretor individual (Figure 9 ), the average monosaccharide length based on mass spectrometry was 7.8 for both secretors and nonsecretors, while monosaccharide analysis after hydrolysis gave 6.7. The higher figure for mass spectrometry could be explained by an overestimation of sialylation and sulfation with mass spectrometry as compared to monosaccharide compositional analysis after acidic hydrolysis. Both ways for the estimation of monosaccharide length show that the larger oligosaccharides described in this paper contribute significantly to the glycosylation of MG2.
Discussion
Si-Le x has previously been detected on MG2 and has therefore been suggested to be a selectin ligand (Prakobphol et al. 1998 ). However, the presence of Si-Le x epitopes was established using antibodies and supported by NMR studies of the oligosaccharide mixture, but only a limited number of glycans were sequenced with mass spectrometry, of which only two were found to express Si-Le x like epitopes. The data presented in the current report give far more detailed information about how these epitopes are presented and suggest that I-type branching would allow multivalent Si-Le x interactions with L-selectin to promote leukocyte adhesion in the oral cavity.
Due to the complex biosynthesis of O-linked oligosaccharides where many isoforms with the same mass are often found, the interpretation of spectra provides an overall picture of glycosylation rather than pinpointing individual structures. Based on the data, the main theme for glycosylation on MG2 can be summarized (Table I ). The fact that there was evidence for type 2 chains of corresponding unfucosylated oligosaccharides by mass spectrometry as well as the high coincidence of Si-Le x epitopes on MG2 as detected by western blotting, both supported a preference for type 2 branch elongation with terminal Si-Le x . By taking into account the structural elements of the major oligosaccharides described here, the number of predicted structures can be calculated, providing a solution space for the type of glycosylation present on salivary MG2. The emerging picture provides an easier accessible description of the glycosylation (compare Table I with supplementary Table I ). Table I provides the information of possible structures but does not provide any information about the relative abundances of individual oligosaccharides. For instance, LC-MS and LC-MS n ( Figure 6 ) indicates that there is one preferred antenna for fucosylation of triantennary blood group I type molecules (intensities of isomers in supplementary Table I ).
The analysis of glycosylation allows insight into the biosynthetic pathway of glycosylation. Having established this pathway of mucin glycosylation on an individual or population basis, it could be speculated about the amount of variation within this pathway that is considered normal. It is our experience that the individual oligosaccharide level could vary significantly within a glycosylation pathway. The pathological conditions are more likely to be related to a shift of a pathway as is the case, for instance, in the change from core 2 to core 1 on MUC1 in cancer (Taylor-Papadimitriou et al. 1999) or induced by infections (Holmén et al. 2002; Olson et al. 2002; Schulz et al. 2004) .
Mucin O-glycans are often terminally glycosylated with sialic acid or fucose residues on the Gal directly linked to C-3 to the reducing-end GalNAc residue. However, the common type short O-linked oligosaccharides of sialyl-T and disialyl-T as well as blood group H epitopes were found to be less abundant on MG2 ( Figure 4A and supplementary Table I ), suggesting that the biosynthesis of these O-linked oligosaccharides is different. The MG2 oligosaccharides described in this report were not only extended on the C-6 branch of the reducing-end GalNAc, which has been described to be the main pathway for complex type O-linked oligosaccharides (Li et al. 1996) but also on the C-3 branch, where both core 1 structures and core 2 structures were found to have terminal Si-Le x or sialyl type 2 N-acetyllactosamine epitopes. The data suggest that one route for generating complex O-linked glycosylation is that the galactose on the C-3 branch of the reducing-end GalNAc of core 1 chains and core 2 chains becomes part of an I-antigen by extending with N-acetyllactosamine on both C-3 and C-6. While similar types of structures as described here have been shown to be present on the Tamm-Horsfall glycoprotein (Easton et al. 2000) , blood group I substances have previously only been indicated in saliva (Dzierzkowa-Borodej et al. 1970) . Until now the main source of these substances has not been identified and structural characterization has not been performed. The enzymes responsible for the branching of the oligosaccharide N-acetyllactosamine backbone described in this report have not been explored. There are currently two candidate glycosyltransferases described with the specificity to be able to branch a linear N-acetyllactosamine from an i-antigen into an I-antigen (Figure 1) , adding GlcNAc to C-6 of a Gal residue. The first candidate is the blood group I transferase, the IGnT enzyme, which has been shown to exist as three isoforms IGnT-1, IGnT-2, and IGnT-3 (Inaba et al. 2003) . The IGnT-3 isoform has been suggested to be responsible for the I-antigen in blood due to its specific expression in bone marrow. The second candidate is the core 2 GlcNAc transferase (C2GnT-M), which in addition to adding GlcNAc to C-6 of the reducing-end GalNAc and by this forming core 2 and core 4 also can synthesize the I-antigen (Schwientek et al. 1999; Yeh et al. 1999) . It has been speculated that the enzyme making blood group I in salivary secretions is different from the one in blood since it has been shown that the saliva from a i individual could be I positive (Marsh et al. 1972) .
A thorough description of the sulfated MG2 oligosaccharides remains to be performed. Monosaccharide analysis and mass spectrometric analyses both suggest that these constitute a minor portion of the MG2 oligosaccharides. It has been concluded that MG2 expresses the MECA-79 epitope (a high-affinity L-selectin ligand: based on 6-sulfo N-acetyllactosamine with or without fucosylation), but at much lower levels than those of MG1 and salivary agglutinin (Prakobphol et al. 2005) . Displaying multivalent sialylated epitopes as been presented in this report would also make MG2 a high-affinity ligand for bacteria with affinity for sialic acid. Pathogenic bacteria such as H. pylori as well as bacteria found in the normal oral flora have been shown to bind to MG2 in a sialic acid-dependent manner.
Taken together, we have shown that MG2 expresses an O-glycan profile that is unique and consistent between individuals, with branched polylactosamine sequence backbones expressing terminal Si-Le x epitopes, and that this O-glycan profile appeared totally different from that of MG1, which carries more blood group epitopes and exhibits large individual variation. Since different cells are responsible for secretion of MUC5B (mucous cells) and MUC7 (serous cells) (Nielsen et al. 1996) , the difference in glycosylation can be attributed to different cellular regulation of glycosyltransferases and their localization in the Golgi stack. The difference in glycosylation will then provide distinct functions of each mucin and how it interacts with specific bacteria and/or leukocyte recruitment. Work is currently underway to characterize the glycosylation of the third high-molecular-weight species in saliva, the salivary agglutinin.
Material and methods
Gel electrophoresis, blotting, and antibody/chemical staining Gels for SDS-agarose/polylacrylamide gel electrophoresis (SDS-AgPAGE) (0.5% agarose, 0-6% polyacrylamide gradient) were made as described (Schulz et al. 2002) and saliva samples prepared, subjected to gel electrophoresis, and blotted onto PVDF membranes (Thomsson et al. 2005) . Saliva (equivalent of 10 µL) from one blood group O secretor individual was separated by SDS-AgPAGE and blotted onto Immobilon-P SQ , and the membranes were blocked overnight at 4
• C using 1% bovine serum albumin and 0.1% Tween 20 in phosphatebuffered saline, pH 7.4. The membranes were then incubated for 1 h in the same solution with antibodies against Si-Le a (C241, x (CSLEX-1, culture supernatant diluted 1/250) from the American Type Culture Collection (Manassas, VA), Blood group H (B2125-19 stock diluted 1/200) from US Biological (Swampscott, MA), or sulfoLe a (MON 1154, 25 µg/mL stock diluted 1/50) from Monosan (Uden, The Netherlands). After washing the membranes three times for 5 min with phosphate-buffered saline, the membranes were incubated for 2 h with a secondary antibody (horseradish peroxidase-labeled sheep anti-mouse (Silenus, Melbourne, Australia) diluted 1/500), or horseradish peroxidase-labeled streptavidin (0.25 µg/mL) (Sigma) in the blocking solution. After five times 5 min washes with phosphate-buffered saline, the blots were developed for 30 min in 1 mg/mL chloronaphthol in methanol:water 1:2 containing 0.0375% hydrogen peroxide. Blots were also stained chemically using high pH Alcian blue (0.125% Alcian blue in 25% ethanol, 10% acetic acid) or low pH Alcian blue (0.125% Alcian blue in 25% ethanol, 10% sulfuric acid) for 10 min and destained in 100% methanol for 20 min.
Protein identification
The MG2 band stained with Alcian Blue was excised from an SDS-AgPAGE gel and washed twice in 50 mM NH 4 HCO 3 in 50% acetonitrile, followed by digestion with trypsin (0.2 µg) (Promega Co., Madison, WI) in 50 mM NH 4 HCO 3 at +34
• C overnight. Peptides were extracted from the gel plug by sonication in 50 mM NH 4 HCO 3 and analyzed by LC-ESI-MS 2 using an ion trap LCQ DECA system (Thermo Electron Co., Waltham, MA) as described previously (Grinyer et al. 2004) , with protein identities assigned by SEQUEST (Thermo Electron), searching human entries in Swiss-Prot/TrEMBL and NCBI protein entries. The criteria for valid peptide assignments were an xCorr score over 2.50 and a CN value over 0.10.
Preparative electrophoresis of MG2
Saliva (10 mL) from the same blood group O secretor individual as above was collected and reduced in 10 mM dithiotreitol at 90
• C for 10 min in the sample loading buffer (Schulz et al. 2002) followed by alkylation in 25 mM iodoacetamide. High-molecular-mass proteins were collected after concentrating the samples to 1000 µL in an Ultrafree-4 centrifugal filter (50 kDa cut off) (Millipore, Bedford, MA). The highmolecular-mass proteins were then loaded onto a preparative SDS-polyacrylamide/agarose composite gel without sample wells. The gels were run, electroblotted onto PVDF, and stained with Alcian blue (Schulz et al. 2002) .
Oligosaccharide release and fractionation
Human salivary MG2 oligosaccharides were released from the preparative blot in 1.0 mL of 0.5 M NaBH 4 in 50 mM NaOH for 16 h. Samples were desalted with 1.0 mL of AG50 W X2 cation exchange beads (Bio-Rad, Hercules, CA) packed in a 1.0 mL Strata C18-E cartridge (Phenomenex, Torrance, CA), and the oligosaccharides were eluted with 10 mL of water and lyophilized. Borate complexes were removed with the repeated (five times) addition of 100 µL of 1% acetic acid in methanol, followed by vacuum centrifugation. Remaining oligosaccharides were dissolved in 1.0 mL of water. Neutral human salivary oligosaccharides (50 µL) were separated from the acidic oligosaccharides by passage through 10 µL of DEAE-Sephadex (Ac − form) (Amersham Biosciences, Uppsala, Sweden) packed on top of a C18 Zip-tip (Millipore). Neutral oligosaccharides were eluted with 200 µL of water and acidified oligosaccharides were eluted with 200 µL 1.0 M pyridinium acetate, pH 5.2. The fractions were dried and redissolved in 50 µL of water and subjected to nano LC-MS 2 (10 µL). An aliquot of the acidic fraction (30 µL) was dried down and dissolved in the reaction buffer and desialylated using S. pneumonia sialidase, 2 µL (approximately 10 mU) (Glyko, Novato, CA) according to manufacturers recommendation and incubated at 37
• C for 16 h. The sample was desalted on homemade micro desalting columns (∼2 µL) containing Carbograph material (Alltech, Deerfield, IL) laid on top of a reverse-phased µ-C18 Zip-tip (Millipore) (Karlsson, Wilson, et al. 2004 ) and subjected to nano LC-MS (10 µL of 20 µL).
Nano LC-MS of MG2 oligosaccharides
Oligosaccharide samples (10 µL) were dissolved in water and injected via a Surveyor autosampler and HPLC system (Thermo Finnigan, San Jose, CA). Solvent A was 10 mM NH 4 HCO 3 and solvent B was 10 mM NH 4 HCO 3 in 80% acetonitrile. The flow rate was 110-120 µL/min, split down before the autosampler into approximately 0.5 µL/min. In line with the ProteCol column with carbon clad Zirkonium (SGE, Ringwood, Australia) (100 mm × 0.15 mm (nano LC) was a 0.5 µm Rep frit (Upchurch Scientific, Oak Harbor, WA). The gradient was developed from 2% to 30% B. The column was then washed with 100% B for 4-7 min and equilibrated with the starting ratio of solvents for at least 12 min. The ProteCol column was connected via a nanoprobe (SGE) to a distal-coated TaperTip emitter (20 µm ID) (New Objective, Woburn, MA). The capillary voltage for the mass spectrometer (LCQ-XP+, Thermo Finnigan) in negative mode was set to 1.1 kV and scanned between m/z 350 and m/z 2000 followed by dependent MS 2 scans of the two most abundant signals from the full scan. Fragmentation analysis of oligosaccharides was performed using the GlycosidIQ glycofragment mass fingerprinting software matching with in silico fragmented oligosaccharides from GlycosuiteDB oligosaccharide database (www.glycosuite.com) or interpreted manually. Conventional nomenclature for the assignment of MS 2 fragmentation of oligosaccharides was adopted (Domon and Costello 1988) .
Semiquantitative analysis of oligosaccharides with capillary LC-MS
Salivary samples from 29 individuals (22 Caucasian, 7 Asian) with known blood groups and secretor/nonsecretor status were prepared and analyzed as described (Thomsson et al. 2005) . Briefly, fresh saliva was reduced and alkylated, followed by analysis with SDS-AgPAGE, and blotting to PVDF membranes. The membranes were stained with Alcian blue, and bands corresponding to MG2 were cut out and the oligosaccharides released with reductive β-elimination followed by desalting on cation exchange resin in a C18 Zip-tip (Millipore). The oligosaccharides were analyzed with negative ion mode capillary LC-MS using carbon columns eluted with an acetonitrile gradient containing 10 mM NH 4 HCO 3 . The chromatograms were processed using the software ACD/Spec Manager (ACD/Laboratories, Toronto, Ontario) as described (Thomsson et al. 2005) . The oligosaccharide peaks were identified and semiquantified using peak area, and from this the relative number of monosaccharide residues estimated in each sample.
